1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Btc Corporation has 1 pending office action currently under review. The prosecution involves 1 distinct examiner, meaning the company's immediate patent strategy is concentrated on a single application and a single point of contact at the patent office.
The busiest examiner identified is CREWS, JARET JAMES, who is responsible for 1 busiest examiner pending office action. This examiner's individual approach will dictate the immediate progress of the company's pending portfolio, as no other examiners are currently assigned to active matters.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CREWS, JARET JAMES | 1 | 44.7% | +70.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18724442 | COMPOSITION FOR IMPROVING EXERCISE PERFORMANCE COMPRISING GYPENOSIDE COMPOUND AS ACTIVE INGREDIENT | CREWS, JARET JAMES | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18724442 | COMPOSITION FOR IMPROVING EXERCISE PERFORMANCE COMPRISING GYPENOSIDE COMPOUND AS ACTIVE INGREDIENT | CREWS, JARET JAMES | — | §102§112DP | Non-Final OA | — | Pending | Jun 26, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial